NowRx was founded in 2015 by Cary Breese. While Breese has not publicly discussed plans to participate in an IPO, NowRx hired Mark Marlow as it's first CFO in February 2022. Throughout his career, Marlow has helped guide two companies through successful IPOs. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

NowRx is a telehealth platform that functions as a digital pharmacy, offering same-day delivery on prescriptions and other medical services. While the company has received funding from traditional VC firms, NowRx has shifted towards a crowdfunding model in recent funding rounds. NowRx has raised $79 million, $20 million of which was raised in a fully crowdfunded round. The latest round increased the company's pre-money valuation to $275 million.

Register for Details

For more details on financing and valuation for NowRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is NowRx's ticker symbol?

NowRx does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is NowRx's stock price?

The stock price for NowRx will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are NowRx's major investors?

Decathlon Capital Partners
Ulu Ventures
Visary Capital
Plug and Play Tech Center
Gershon Capital
Logical Venture Partners
Envlp Ventures

NowRx Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
10/7/2021 Series C $334.19MM $XXX.XX $XXX.XX
7/15/2020 Series B $98.38MM $XXX.XX $XXX.XX
10/16/2018 Series A $57.07MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about NowRx

Forge green plus iconForge green minus icon

What is NowRx funding to date?

NowRx has raised $114.11MM with the following series:
$57.07MM for Series A, $98.38MM for Series B, $334.19MM for Series C, $57.07MM for Series A, $98.38MM for Series B, $334.19MM for Series C.
Forge green plus iconForge green minus icon

When was NowRx founded?

NowRx was founded in 2015.
Forge green plus iconForge green minus icon

Can you invest in NowRx?

NowRx is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell NowRx share pre-IPO?

If you own NowRx pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is NowRx a publicly traded company?

NowRx is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like NowRx in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation